Role of nicotinamide in DNA damage, mutagenesis, and DNA repair

Journal of Nucleic Acids

Volumn 2010, Issue , 2010, Pages

  Surjana, Devita ^a   Halliday, Gary M ^a   Damian, Diona L ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINIC ACID; PROTEIN P53;

BREAST ADENOCARCINOMA; CANCER CHEMOTHERAPY; CANCER MODEL; CANCER PREVENTION; CARCINOGENESIS; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENOMIC INSTABILITY; HUMAN; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SKIN CANCER; ULTRAVIOLET RADIATION; VITAMIN SUPPLEMENTATION;

ANIMALIA;

EID: 79955408736     PISSN: 20900201     EISSN: 2090021X     Source Type: Journal    
DOI: 10.4061/2010/157591     Document Type: Review

References (152)

1. Jacob R. A., Swendseid M. E., Ziegler E. E., Filer L. J., Niacin. Present Knowledge in Nutrition 1996 Washington, DC, USA ILSI Press 184 190
2. Benavente C. A., Jacobson M. K., Jacobson E. L., NAD in skin: therapeutic approaches for niacin. Current Pharmaceutical Design 2009 15 1 29 38 2-s2.0-62149099631 10.2174/138161209787185760
3. Karthikeyan K., Thappa D. M., Pellagra and skin. International Journal of Dermatology 2002 41 8 476 481 2-s2.0-0036671464 10.1046/j.1365-4362.2002.01551. x (Pubitemid 35021485)
4. Nutrient Reference Values for Australian and New Zealand, including recommended dietary intake. pp.1-329, National Health and Medical Research Council publication, Canberra, Australia, 2006
5. Jackson T. M., Rawling J. M., Roebuck B. D., Kirkland J. B., Large supplements of nicotinic acid and nicotinamide increase tissue NAD+ and poly(ADP-ribose) levels but do not affect diethylnitrosamine-induced altered hepatic foci in Fischer-344 rats. Journal of Nutrition 1995 125 6 1455 1461 2-s2.0-0029050644
6. Jacobson E. L., Dame A. J., Pyrek J. S., Jacobson M. K., Evaluating the role of niacin in human carcinogenesis. Biochimie 1995 77 5 394 398 2-s2.0-0029099175 10.1016/0300-9084(96)88152-1
7. Cosmetic Ingredient Review (CIR) Expert Panel, Final report of the safety assessment of niacinamide and niacin. International Journal of Toxicology 2005 24 1 31
8. Denekamp J., Fowler J. F., ARCON - current status: summary of a workshop on preclinical and clinical studies. Acta Oncologica 1997 36 5 517 525 2-s2.0-0030819542 (Pubitemid 27372146)
9. Winter S. L., Boyer J. L., Hepatic toxicity from large doses of vitamin-B3 (Nicotinamide). New England Journal of Medicine 1973 289 22 1180 1182 2-s2.0-0015851483
10. Kaanders J. H. A. M., Stratford M. R. L., Liefers J., Dennis M. F., Van der Kogel A. J., Van Daal W. A. J., Rojas A., Administration of nicotinamide during a five- to seven-week course of radiotherapy: pharmacokinetics, tolerance, and compliance. Radiotherapy and Oncology 1997 43 1 67 73 2-s2.0-0030890096 10.1016/S0167-8140(96)01896-8 (Pubitemid 27191981)
11. Ranchoff R. E., Tomecki K., Niacin or niacinamide? Nicotinic acid or nicotinamide? What is the difference? Journal of the American Academy of Dermatology 1986 15 1 116 117 2-s2.0-0022568992 (Pubitemid 16090907)
12. Meyer-Ficca M. L., Meyer R. G., Jacobson E. L., Jacobson M. K., Poly(ADP-ribose) polymerases: managing genome stability. International Journal of Biochemistry and Cell Biology 2005 37 5 920 926 2-s2.0-14644393675 10.1016/j.biocel.2004.09.011 (Pubitemid 40311734)
13. Hendricks W. M., Pellagra and pellagralike dermatoses: etiology, differential diagnosis, dermatopathology, and treatment. Seminars in Dermatology 1991 10 4 282 292 2-s2.0-0026410934
14. Chambon P., Weill J. D., Mandel P., Nicotinamide mononucleotide activation of a new DNA-dependent polyadenylic acid synthesizing nuclear enzyme. Biochemical and Biophysical Research Communications 1963 11 1 39 43 2-s2.0-0002160618
15. Oliver F. J., Menissier-de Murcia J., De Murcia G., Poly(ADP-Ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease. American Journal of Human Genetics 1999 64 5 1282 1288 2-s2.0-0033362084 10.1086/302389 (Pubitemid 30468745)
16. Kamat J. P., Devasagayam T. P. A., Methylene blue plus light-induced lipid peroxidation in rat liver microsomes: inhibition by nicotinamide (vitamin B3) and other antioxidants. Chemico-Biological Interactions 1996 99 1-3 1 16 2-s2.0-0030061559 10.1016/0009-2797(95)03653-9 (Pubitemid 26042952)
17. Yamada K., Nonaka K., Hanafusa T., Miyazaki A., Toyoshima H., Tarui S., Preventative and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis-an observation in non-obese diabetic (NOD) mice. Diabetes 1982 31 9 749 753 (Pubitemid 12062862)
18. Abdallah D. M., Nicotinamide alleviates indomethacin-induced gastric ulcers: a novel antiulcer agent. European Journal of Pharmacology 2010 627 1-3 276 280 2-s2.0-70350715082 10.1016/j.ejphar.2009.10.037
19. Vincent A. M., Stevens M. J., Backus C., Mclean L. L., Feldman E. L., Cell culture modeling to test therapies against hyperglycemia-mediated oxidative stress and injury. Antioxidants and Redox Signaling 2005 7 11-12 1494 1506 2-s2.0-28844481889 10.1089/ars.2005.7.1494 (Pubitemid 41767985)
20. Wilson G. L., Patton N. J., McCord J. M., Mechanisms of streptozotocin- and alloxan-induced damage in the rat B-cells. Diabetologia 1984 27 6 587 591 2-s2.0-0021677837 (Pubitemid 15178770)
21. Vu C. Q., Coyle D. L., Tai H. H., Jacobson E. L., Jacobson M. K., Haag F., Koch-Nolte F., Intramolecular ADP-ribose transfer reactions and calcium signalling. ADP-Ribosylation in Animal Tissue: Structure, Function, and Biology of Mono-ADP-Ribosyltransferases and Related Enzymes 1997 New York, NY, USA Plenum Press 381 388
22. Vu C. O., Coyle D. L., Jacobson E. L., Jacobson M. K., Intracellular signaling by cylic ADP-Ribose in oxidative cell injury. FASEB Journal 1997 11 9 1522 2-s2.0-4244090946
23. Jacobson E. L., Shieh W. M., Huang A. C., Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis. Molecular and Cellular Biochemistry 1999 193 1-2 69 74 2-s2.0-0032920624 (Pubitemid 29176583)
24. Blot W. J., Li J.-Y., Taylor P. R., Guo W., Dawsey S., Wang G.-Q., Yang C. S., Zheng S.-F., Gail M., Li G.-Y., Yu Y., Liu B.-Q., Tangrea J., Sun Y.-H., Liu F., Fraumeni J. F. Jr., Zhang Y.-H., Li B., Nutrition intervention trials in Linxian, China. Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. Journal of the National Cancer Institute 1993 85 18 1483 1492 2-s2.0-0027275148 (Pubitemid 23269183)
25. Franceschi S., Bidoli E., Baron A. E., La Vecchia C., Maize and risk of cancers of the oral cavity, pharynx, and esophagus in Northeastern Italy. Journal of the National Cancer Institute 1990 82 17 1407 1411 2-s2.0-0025142967 (Pubitemid 20261054)
26. Negri E., Franceschi S., Bosetti C., Levi F., Conti E., Parpinel M., La Vecchia C., Selected micronutrients and oral and pharyngeal cancer. International Journal of Cancer 2000 86 1 122 127 2-s2.0-0034053112 (Pubitemid 30133997)
27. Siassi F., Pouransari Z., Ghadirian P., Nutrient intake and esophageal cancer in the caspian littoral of Iran: a case-control study. Cancer Detection and Prevention 2000 24 3 295 303 2-s2.0-0033844984 (Pubitemid 30656738)
28. Kabat G. C., Miller A. B., Jain M., Rohan T. E., Dietary intake of selected B vitamins in relation to risk of major cancers in women. British Journal of Cancer 2008 99 5 816 821 2-s2.0-50249108914 10.1038/sj.bjc.6604540
29. Zablotska L. B., Chen Y., Graziano J. H., Parvez F., van Geen A., Howe G. R., Ahsan H., Protective effects of B vitamins and antioxidants on the risk of arsenic-related skin lesions in Bangladesh. Environmental Health Perspectives 2008 116 8 1056 1062 2-s2.0-51249098135 10.1289/ehp.10707
30. Pelucchi C., Tramacere I., Bertuccio P., Tavani A., Negri E., La Vecchia C., Dietary intake of selected micronutrients and gastric cancer risk: an Italian case-control study. Annals of Oncology 2009 20 1 160 165 2-s2.0-58949093772 10.1093/annonc/mdn536
31. Qu C.-X., Kamangar F., Fan J.-H., Yu B., Sun X.-D., Taylor P. R., Chen B. E., Abnet C. C., Qiao Y.-L., Mark S. D., Dawsey S. M., Chemoprevention of primary liver cancer: a randomized, double-blind trial in Linxian, China. Journal of the National Cancer Institute 2007 99 16 1240 1247 2-s2.0-34548131205 10.1093/jnci/djm084 (Pubitemid 47299902)
32. Bosetti C., Scotti L., Dal Maso L., Talamini R., Montella M., Negri E., Ramazzotti V., Franceschi S., La Vecchia C., Micronutrients and the risk of renal cell cancer: a case-control study from Italy. International Journal of Cancer 2007 120 4 892 896 2-s2.0-33846637266 10.1002/ijc.22374 (Pubitemid 46175412)
33. Jacobson E. L., Niacin deficiency and cancer in women. Journal of the American College of Nutrition 1993 12 4 412 416 2-s2.0-0027321708 (Pubitemid 23228289)
34. Inculet R. I., Norton J. A., Nichoalds G. E., Water-soluble vitamins in cancer patients on parenteral nutrition: a prospective study. Journal of Parenteral and Enteral Nutrition 1987 11 3 243 249 (Pubitemid 17078039)
35. Dreizen S., McCredie K. B., Keating M. J., Andersson B. S., Nutritional deficiencies in patients receiving cancer chemotherapy. Postgraduate Medicine 1990 87 1 163 170 2-s2.0-0025064383 (Pubitemid 20041617)
36. Stevens H. P., Ostlere L. S., Begent R. H. J., Dooley J. S., Rustin M. H. A., Pellagra secondary to 5-fluorouracil. British Journal of Dermatology 1993 128 5 578 580 2-s2.0-0027173928 10.1111/j.1365-2133.1993.tb00240.x (Pubitemid 23155960)
37. Op Het Veld C. W., Van Hees-Stuivenberg S., Van Zeeland A. A., Jansen J. G., Effect of nucleotide excision repair on hprt gene mutations in rodent cells exposed to DNA ethylating agents. Mutagenesis 1997 12 6 417 424 2-s2.0-0030829126 (Pubitemid 27503895)
38. Felix C. A., Secondary leukemias induced by topoisomerase-targeted drugs. Biochimica et Biophysica Acta 1998 1400 1-3 233 255 2-s2.0-0032189081 10.1016/S0167-4781(98)00139-0 (Pubitemid 28475107)
39. Kirkland J. B., Niacin and carcinogenesis. Nutrition and Cancer 2003 46 2 110 118 2-s2.0-0344197087 (Pubitemid 37500503)
40. Toth B., Lack of carcinogenicity of nicotinamide and isonicotinamide following lifelong administration to mice. Oncology 1983 40 1 72 75 2-s2.0-0020680067 (Pubitemid 13216969)
41. French F. A., Schrauzer G. N., The influence of nutritional factors on pulmonary adenomas in mice. Inorganic and Nutritional Aspects of Cancer 1978 New York, NY, USA Plenum Press
42. Gotoh H., Nomura T., Nakajima H., Hasegawa C., Sakamoto Y., Inhibiting effects of nicotinamide on urethane-induced malformations and tumors in mice. Mutation Research 1988 199 1 55 63 2-s2.0-0023908882
43. Bartleman A.-P., Jacobs R., Kirkland J. B., Niacin supplementation decreases the incidence of alkylation-induced nonlymphocytic leukemia in long-evans rats. Nutrition and Cancer 2008 60 2 251 258 2-s2.0-41449091343 10.1080/01635580701649628 (Pubitemid 351454025)
44. Gotoh H., Nomura T., Hasegawa C., Growth-inhibition of transplanted murine-breast cancer by nicotinamide in C3H/HEJ mice. Cancer Research Therapy and Control 1993 3 2 121 126
45. Horsman M. R., Khalil A. A., Chaplin D. J., Overgaard J., The ability of nicotinamide to inhibit the growth of a C3H mouse mammary carcinoma. Acta Oncologica 1995 34 3 443 446 2-s2.0-0029018913
46. Schoental R., The role of nicotinamide and of certain other modifying factors in diethylnitrosamine carcinogenesis: fusaria mycotoxins and spontaneous tumors in animals and man. Cancer 1977 40 4 1833 1840 2-s2.0-0017716032 (Pubitemid 8216953)
47. Rosenberg M. R., Novicki D. L., Jirtle R. L., Promoting effect of nicotinamide on the development of renal tubular cell tumors in rats initiated with diethylnitrosamine. Cancer Research 1985 45 2 809 814 (Pubitemid 15161084)
48. Rakieten N., Gordon B. S., Beaty A., Cooney D. A., Davis R. D., Schein P. S., Pancreatic islet cell tumors produced by the combined action of streptozotocin and nicotinamide. Proceedings of the Society for Experimental Biology and Medicine 1971 137 1 280 283 2-s2.0-0015060630
49. Rakieten N., Gordon B. S., Beaty A., Modification of renal tumorigenic effect of streptozotocin by nicotinamide: spontaneous reversibility of streptozotocin diabetes. Proceedings of the Society for Experimental Biology and Medicine 1976 151 2 356 361
50. Schoental R., Pancreatic islet cell and other tumors in rats given heliotrine, a monoester pyrrolizidine alkaloid, and nicotinamide. Cancer Research 1975 35 8 2020 2024
51. Burkart V., Wang Z.-Q., Radons J., Heller B., Herceg Z., Stingl L., Wagner E. F., Kolb H., Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nature Medicine 1999 5 3 314 319 2-s2.0-0033011114 10.1038/6535 (Pubitemid 29124368)
52. Gensler H. L., Prevention of photoimmunosuppression and photocarcinogenesis by topical nicotinamide. Nutrition and Cancer 1997 29 2 157 162 2-s2.0-0031470571 (Pubitemid 28009838)
53. Gensler H. L., Williams T., Huang A. C., Jacobson E. L., Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice. Nutrition and Cancer 1999 34 1 36 41 2-s2.0-0032854152 (Pubitemid 29382913)
54. Ludwig A., Dietel M., Schafer G., Muller K., Hilz H., Nicotinamide and nicotinamide analogues as antitumor promoters in mouse skin. Cancer Research 1990 50 8 2470 2475 2-s2.0-0025261737 (Pubitemid 20134512)
55. Roe F. J. C., Effect of massive doses of riboflavin, and other vitamins of the B group, on skin carcinogenesis in mice. British Journal of Cancer 1964 16 252 257
56. Pamukcu A. M., Milli U., Bryan G. T., Protective effect of nicotinamide on bracken fern inducec carcinogenecity in rats. Nutrition and Cancer 1981 3 86
57. Pour P. M., Lawson T., Modification of pancreatic carcinogenesis in the hamster model. XV. Preventive effect of nicotinamide. Journal of the National Cancer Institute 1984 73 3 767 770 2-s2.0-0021202385 (Pubitemid 14000214)
58. Moloney F. J., Comber H., O'Lorcain P., O'Kelly P., Conlon P. J., Murphy G. M., A population-based study of skin cancer incidence and prevalence in renal transplant recipients. British Journal of Dermatology 2006 154 3 498 504 2-s2.0-33644924057 10.1111/j.1365-2133.2005.07021.x (Pubitemid 43382659)
59. Halliday G. M., Honigsmann H., Lim H. W., Draelos Z. D., Sunscreens, photoimmunosuppression, and photoaging. Clinical Guide to Sunscreeens and Photoprotection 2009 New York, NY, USA Informa Healthcare USA, Inc 101 116
60. Halliday G. M., Bestak R., Yuen K. S., Cavanagh L. L., Barnetson R. S. C., UVA-induced immunosuppression. Mutation Research 1998 422 1 139 145 2-s2.0-0032501131 10.1016/S0027-5107(98)00185-7 (Pubitemid 28515622)
61. Damian D. L., Barnetson R. S. C., Halliday G. M., Low-dose UVA and UVB have different time courses for suppression of contact hypersensitivity to a recall antigen in humans. Journal of Investigative Dermatology 1999 112 6 939 944 2-s2.0-0033064052 10.1046/j.1523-1747.1999.00610.x (Pubitemid 29277996)
62. Applegate L. A., Ley R. D., Alcalay J., Kripke M. L., Identification of the molecular target for the suppression of contact hypersensitivity by ultraviolet radiation. Journal of Experimental Medicine 1989 170 4 1117 1131 2-s2.0-0024442538 (Pubitemid 19250683)
63. Damian D. L., Patterson C. R. S., Stapelberg M., Park J., Barnetson R. S. C., Halliday G. M., UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. Journal of Investigative Dermatology 2008 128 2 447 454 2-s2.0-38149129185 10.1038/sj.jid.5701058
64. Yiasemides E., Sivapirabu G., Halliday G. M., Park J., Damian D. L., Oral nicotinamide protects against ultraviolet radiation-induced immunosuppression in humans. Carcinogenesis 2009 30 1 101 105 2-s2.0-58949083732 10.1093/carcin/bgn248
65. Damian D. L., Halliday G. M., Measurement of ultraviolet radiation-induced suppression of recall contact and delayed-type hypersensitivity in humans. Methods 2002 28 1 34 45 2-s2.0-0036385948 10.1016/S1046-2023(02)00208-6
66. Sivapirabu G., Yiasemides E., Halliday G. M., Park J., Damian D. L., diona.damian@email.cs.nsw.gov.au Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans. British Journal of Dermatology 2009 161 6 1357 1364 2-s2.0-33744916194 10.1111/j.1365-2133.2009.09244.x
67. De Murcia G., Schreiber V., Molinete M., Saulier B., Poch O., Masson M., Niedergang C., Menissier-De Murcia J., Structure and function of poly(ADP-ribose) polymerase. Molecular and Cellular Biochemistry 1994 138 1-2 15 24 2-s2.0-0028113249 10.1007/BF00928438 (Pubitemid 24365390)
68. De Murcia G., Menissier-de Murcia J., Poly(ADP-ribose) polymerase: a molecular nick-sensor. Trends in Biochemical Sciences 1994 19 4 172 176 2-s2.0-0000102949 10.1016/0968-0004(94)90280-1 (Pubitemid 24115433)
69. Shall S., De Murcia G., Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model? Mutation Research 2000 460 1 1 15 2-s2.0-0034733928 10.1016/S0921-8777(00)00016-1 (Pubitemid 30365046)
70. Virág L., Szabó C., The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacological Reviews 2002 54 3 375 429 2-s2.0-0036733355 10.1124/pr.54.3.375
71. Hageman G. J., Stierum R. H., Niacin, poly(ADP-ribose) polymerase-1 and genomic stability. Mutation Research 2001 475 1-2 45 56 2-s2.0-0035906329 10.1016/S0027-5107(01)00078-1 (Pubitemid 32280802)
72. +-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 2004 119 6 803 814 2-s2.0-10944227347 10.1016/j.cell.2004.11.002 (Pubitemid 40017687)
73. Skaper S. D., Slikkerandr W., Andrews J., Trembly B., Poly(ADP-ribose) polymerase-1 in acute neuronal death and inflammation - a strategy for neuroprotection. Neuroprotective Agents 2003 New York, NY, USA The New York Academy of Sciences 217 228 (Pubitemid 36808453)
74. Stierum R. H., Van Herwijnen M. H. M., Hageman G. J., Kleinjans J. C. S., Increased poly(ADP-ribose) polymerase activity during repair of (±)-anti-benzo[a]pyrene diolepoxide-induced DNA damage in human peripheral blood lymphocytes in vitro. Carcinogenesis 1994 15 4 745 751 2-s2.0-0028346261 (Pubitemid 24124422)
75. Trucco C., Oliver F. J., De Murcia G., Menissier-de Murcia J., DNA repair defect in poly(ADP-ribose) polymerase-deficient cell lines. Nucleic Acids Research 1998 26 11 2644 2649 2-s2.0-0032102896 10.1093/nar/26.11.2644 (Pubitemid 28297377)
76. Molinete M., Vermeulen W., Burkle A., Overproduction of the poly(ADP-ribose)polymerase DNA-binding domain blocks alkylation-induced DNA-repair synthesis in mammalian-cells. Embo Journal 1993 12 5 2109 2117 (Pubitemid 23157726)
77. Ding R., Smulson M., Depletion of nuclear poly(ADP-ribose)polymerase by antisense RNA expression-influences on genomic stability, chromatin organization and DNA-repair. Faseb Journal 1994 8 7 A1409 2-s2.0-0028145365
78. Dantzer F., Nasheuer H. P., Vonesch J. L., de Murcia G., Menissier-de Murcia J., Functional association of poly(ADP-ribose) polymerase with DNA polymerase alpha-primase complex: a link between DNA strand break detection and DNA replication. Nucleic Acids Research 1998 26 8 1891 1898 (Pubitemid 28291721)
79. Satoh M. S., Poirier G. G., Lindahl T., Dual function for poly(ADP-ribose) synthesis in response to DNA strand breakage. Biochemistry 1994 33 23 7099 7106 2-s2.0-0028365745 (Pubitemid 24208746)
80. Chatterjee S., Berger S. J., Berger N. A., Poly(ADP-ribose) polymerase: a guardian of the genome that facilitates DNA repair by protecting against DNA recombination. Molecular and Cellular Biochemistry 1999 193 1-2 23 30 2-s2.0-0032942257 (Pubitemid 29176577)
81. Trucco C., Rolli V., Oliver F. J., Flatter E., Masson M., Dantzer F., Niedergang C., Dutrillaux B., Menissier-de Murcia J., De Murcia G., A dual approach in the study of poly (ADP-ribose) polymerase: in vitro random mutagenesis and generation of deficient mice. Molecular and Cellular Biochemistry 1999 193 1-2 53 60 2-s2.0-0032947934 (Pubitemid 29176581)
82. Masutani M., Nozaki T., Nakamoto K., Nakagama H., Suzuki H., Kusuoka O., Tsutsumi M., Sugimura T., The response of Parp knockout mice against DNA damaging agents. Mutation Research 2000 462 2-3 159 166 2-s2.0-0034109623 10.1016/S1383-5742(00)00033-8 (Pubitemid 30190223)
83. Wang Z.-Q., Stingl L., Morrison C., Jantsch M., Los M., Schulze-Osthoff K., Wagner E. F., PARP is important for genomic stability but dispensable in apoptosis. Genes and Development 1997 11 18 2347 2358 2-s2.0-0030984490 (Pubitemid 27408532)
84. Menissier-de Murcia J., Niedergang C., Trucco C., Ricoul M., Dutrillaux B., Mark M., Oliver F. J., Masson M., Dierich A., Lemeur M., Walztinger C., Chambon P., De Murcia G., Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells. Proceedings of the National Academy of Sciences of the United States of America 1997 94 14 7303 7307 2-s2.0-0040984333 10.1073/pnas.94.14.7303 (Pubitemid 27345310)
85. Tsutsumi M., Masutani M., Nozaki T., Kusuoka O., Tsujiuchi T., Nakagama H., Suzuki H., Konishi Y., Sugimura T., Increased susceptibility of poly(ADP-ribose) polymerase-1 knockout mice to nitrosamine carcinogenicity. Carcinogenesis 2001 22 1 1 3 2-s2.0-0035132977 (Pubitemid 32098137)
86. Di Fagagna F. D., Hande M. P., Tong W.-M., Lansdorp P. M., Wang Z.-Q., Jackson S. P., Functions of poly(ADP-ribose) polymerase in controlling telomere length and chromosomal stability. Nature Genetics 1999 23 1 76 80 2-s2.0-0032842477 10.1038/12680 (Pubitemid 29418792)
87. Osley M. A., Tsukuda T., Nickoloff J. A., ATP-dependent chromatin remodeling factors and DNA damage repair. Mutation Research 2007 618 1-2 65 80 2-s2.0-34147162118 10.1016/j.mrfmmm.2006.07.011 (Pubitemid 46574743)
88. + precursor nicotinamide. Current Medicinal Chemistry 2006 13 8 883 895 2-s2.0-33645999375 10.2174/ 092986706776361058 (Pubitemid 43674510)
89. Durkacz B. W., Omidiji O., Gray D. A., Shall S., (ADP-ribose)n participates in DNA excision repair. Nature 1980 283 5747 593 596 2-s2.0-0018906390 (Pubitemid 10136042)
90. Jacobson E. L., Giacomoni P. U., Roberts M. J., Wondrak G. T., Jacobson M. K., Optimizing the energy status of skin cells during solar radiation. Journal of Photochemistry and Photobiology B 2001 63 1-3 141 147 2-s2.0-0035473031 10.1016/S1011-1344(01)00211-1 (Pubitemid 33040732)
91. Benavente C. A., Jacobson E. L., Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytes. Free Radical Biology and Medicine 2008 44 4 527 537 2-s2.0-38649118533 10.1016/j. freeradbiomed.2007.10.006 (Pubitemid 351172713)
92. Weitberg A. B., Effect of nicotinic acid supplementation in vivo on oxygen radical-induced genetic damage in human lymphocytes. Mutation Research 1989 216 4 197 201 2-s2.0-0024387392 (Pubitemid 19215564)
93. Berger N. A., Sikorski G. W., Nicotinamide stimulates repair of DNA damage in human lymphocytes. Biochemical and Biophysical Research Communications 1980 95 1 67 72 2-s2.0-0018931449 (Pubitemid 10015738)
94. Sims J. L., Berger S. J., Berger N. A., Effects of nicotinamide on NAD and poly(ADP-ribose) metabolism in DNA-damaged human lymphocytes. Journal of Supramolecular and Cellular Biochemistry 1981 16 3 281 288 2-s2.0-0019790092 (Pubitemid 12213943)
95. Kjellen E., Jonsson G. G., Pero R. W., Christensson P.-I., Effects of hyperthermia and nicotinamide on DNA repair synthesis, ADP-ribosyl transferase activity, NAD+ and ATP pools, and cytotoxicity in γ -irradiated human mononuclear leukocytes. International Journal of Radiation Biology 1986 49 1 151 162 2-s2.0-0022632047 (Pubitemid 16174937)
96. Cleaver J. E., Trosko J. E., Defective stage of DNA repair in a human disease, xeroderma pigmentosum. Radiation Research 1969 39 2 471
97. Miwa M., Kanai M., Kondo T., Hoshino H., Ishihara K., Sugimura T., Inhibitors of poly(ADP-ribose)polymerase enhance unscheduled DNA-synthesis in human peripheral lymphocytes. Biochemical and Biophysical Research Communications 1981 100 1 463 470 (Pubitemid 12232579)
98. Tang K., Sham H., Hui E., Kirkland J. B., Niacin deficiency causes oxidative stress in rat bone marrow cells but not through decreased NADPH or glutathione status. Journal of Nutritional Biochemistry 2008 19 11 746 753 2-s2.0-53149136711 10.1016/j.jnutbio.2007.10.003
99. Melnikova V. O., Ananthaswamy H. N., Cellular and molecular events leading to the development of skin cancer. Mutation Research 2005 571 1-2 91 106 2-s2.0-14644405691 10.1016/j.mrfmmm.2004.11.015 (Pubitemid 40313435)
100. Svobodova A., Walterova D., Vostalova J., Ultraviolet light induced alteration to the skin. Biomedical papers of the Medical Faculty of the University Palack Olomouc, Czechoslovakia 2006 150 1 25 38 2-s2.0-33847643032
101. Halliday G. M., Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutation Research 2005 571 1-2 107 120 2-s2.0-14644419658 10.1016/j.mrfmmm.2004. 09.013 (Pubitemid 40313436)
102. Boyonoski A. C., Spronck J. C., Gallacher L. M., Jacobs R. M., Shah G. M., Guy P. G., Kirkland J. B., Niacin deficiency decreases bone marrow poly(ADP-ribose) and the latency of ethylnitrosourea-induced carcinogenesis in rats. Journal of Nutrition 2002 132 1 108 114 2-s2.0-0036137968 (Pubitemid 34042463)
103. Spronck J. C., Kirkland J. B., Niacin deficiency increases spontaneous and etoposide-induced chromosomal instability in rat bone marrow cells in vivo. Mutation Research 2002 508 1-2 83 97 2-s2.0-0037206611 10.1016/S0027-5107(02) 00188-4
104. Spronck J. C., Nickerson J. L., Kirkland J. B., Niacin deficiency alters p53 expression and impairs etoposide-induced cell cycle arrest and apoptosis in rat bone marrow cells. Nutrition and Cancer 2007 57 1 88 99 2-s2.0-34249907589 (Pubitemid 46871573)
105. Kostecki L. M., Thomas M., Linford G., Lizotte M., Toxopeus L., Bartleman A.-P., Kirkland J. B., Niacin deficiency delays DNA excision repair and increases spontaneous and nitrosourea-induced chromosomal instability in rat bone marrow. Mutation Research 2007 625 1-2 50 61 2-s2.0-35548963303 10.1016/j.mrfmmm.2007.05.008 (Pubitemid 350016105)
106. Kirkland J. B., Niacin status and treatment-related leukemogenesis. Molecular Cancer Therapeutics 2009 8 4 725 732 2-s2.0-66449134807 10.1158/1535-7163.MCT-09-0042
107. Rolli V., Armin R., Augustin A., Schulz G., Menissier-de Murcia J., de Murcia G., Poly ADP-Ribosylation Reactions: From DNA Damage and Stress Signalling to Cell Death 2000 Oxford, UK Oxford University Press
108. Kass G. E. N., Eriksson J. E., Weis M., Orrenius S., Chow S. C., Chromatin condensation during apoptosis requires ATP. Biochemical Journal 1996 318 3 749 752 2-s2.0-0029784511 (Pubitemid 26320935)
109. Richter C., Schweizer M., Cossarizza A., Franceschi C., Control of apoptosis by the cellular ATP level. FEBS Letters 1996 378 2 107 110 2-s2.0-0030069231 10.1016/0014-5793(95)01431-4 (Pubitemid 26015556)
110. Stefanelli C., Bonavita F., Stanic' I., Farruggia G., Falcieri E., Robuffo I., Pignatti C., Muscari C., Rossoni C., Guarnieri C., Caldarera C. M., ATP depletion inhibits glucocorticoid-induced thymocyte apoptosis. Biochemical Journal 1997 322 3 909 917 2-s2.0-0030896644 (Pubitemid 27135643)
111. Ferrari D., Stepczynska A., Los M., Wesselborg S., Schulze-Osthoff K., Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis. Journal of Experimental Medicine 1998 188 5 979 984 2-s2.0-0032494108 10.1084/jem.188.5.979 (Pubitemid 28433424)
112. Park S. D., Kim C. G., Kim M. G., Inhibitors of poly(ADP-ribose) polymerase enhance DNA strand breaks, excision repair, and sister chromatid exchanges induced by alkylating agents. Environmental Mutagenesis 1983 5 4 515 525 2-s2.0-0020960321 (Pubitemid 13013193)
113. Pero R. W., Axelsson B., Siemann D., Chaplin D., Dougherty G., Newly discovered anti-inflammatory properties of the benzamides and nicotinamides. Molecular and Cellular Biochemistry 1999 193 1-2 119 125 2-s2.0-0032917035 (Pubitemid 29176591)
114. Riklis E., Kol R., Marko R., Trends and developments in radioprotection: the effect of nicotinamide on DNA repair. International Journal of Radiation Biology 1990 57 4 699 708 2-s2.0-0025230367 (Pubitemid 20115268)
115. Zheng H., Olive P. L., olive@unixgubc.ca Reduction of tumor hypoxia and inhibition of DNA repair by nicotinamide after irradiation of SCCVII murine tumors and normal tissues. Cancer Research 1996 56 12 2801 2808 2-s2.0-0027518136 (Pubitemid 26175740)
116. Althaus F. R., Lawrence S. D., Sattler G. L., Pitot H. C., The effect of nicotinamide on unscheduled DNA synthesis in cultured hepatocytes. Biochemical and Biophysical Research Communications 1980 95 3 1063 1070 2-s2.0-0019324325
117. Oikawa A., Tohda H., Kanai M., Miwa M., Sugimura T., Inhibitors of poly(adenosine diphosphate ribose) polymerase induce sister chromatid exhanges. Biochemical and Biophysical Research Communications 1980 97 4 1311 1316 2-s2.0-0019270633 (Pubitemid 11148283)
118. Utakoji T., Hosoda K., Umezawa K., Sawamura M., Induction of sister chromatid exchanges by nicotinamide in chinese-hamster lung fibroblasts and human-lymphoblastoid cells. Biochemical and Biophysical Research Communications 1979 90 4 1147 1152 (Pubitemid 10195917)
119. Kirkland J. B., Niacin status, NAD distribution and ADP-ribose metabolism. Current Pharmaceutical Design 2009 15 1 3 11 2-s2.0-62149150332 10.2174/138161209787185823
120. Rankin P. W., Jacobson E. L., Benjamin R. C., Moss J., Jacobson M. K., Quantitative studies of inhibitors of ADP-ribosylation invitro and invivo. Journal of Biological Chemistry 1989 264 8 4312 4317 (Pubitemid 19081328)
121. Thies R. L., Autor A. P., Reactive oxygen injury to cultured pulmonary artery endothelial cells: mediation by poly(ADP-ribose) polymerase activation causing NAD depletion and altered energy balance. Archives of Biochemistry and Biophysics 1991 286 2 353 363 2-s2.0-0025854916
122. Hoyt D. G., Lazo J. S., NAD depletion after in vitro exposure of murine lung slices to bleomycin. Biochemical Pharmacology 1993 46 10 1819 1824 2-s2.0-0027373408 10.1016/0006-2952(93)90588-N (Pubitemid 23349031)
123. Farkas B., Magyarlaki M., Csete B., Nemeth J., Rabloczky G., Bernath S., Literáti Nagy P., Sümegi B., Reduction of acute photodamage in skin by topical application of a novel PARP inhibitor. Biochemical Pharmacology 2002 63 5 921 932 2-s2.0-0036496950 10.1016/S0006-2952(01)00929-7 (Pubitemid 34243005)
124. Tronov V. A., Konstantinov E. M., Petrakou E., Tsilimigaki S., Piperakis S. M., Nicotinamide "protects" resting lymphocytes exposed to hydrogen peroxide from necrosis but not from apoptosis. Cell Biology and Toxicology 2002 18 6 359 367 2-s2.0-0036439075 10.1023/A:1020859405262 (Pubitemid 35396700)
125. Coppola S., Nosseri C., Maresca V., Ghibelli L., Different basal NAD levels determine opposite effects of poly(ADP- ribosyl)polymerase inhibitors on H2O2-induced apoptosis. Experimental Cell Research 1995 221 2 462 469 2-s2.0-0028841484 10.1006/excr.1995.1397
126. + prevents apoptosis in the mouse brain induced by tertiary-butylhydroperoxide. Neuroscience Letters 1996 206 1 5 8 2-s2.0-0029919729 10.1016/0304-3940(96)12446-0 (Pubitemid 26086272)
127. Leist M., Single B., Castoldi A. F., Kühnle S., Nicotera P., Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. Journal of Experimental Medicine 1997 185 8 1481 1486 2-s2.0-0030900980 10.1084/jem.185.8.1481 (Pubitemid 27187604)
128. Leist M., Single B., Naumann H., Fava E., Simon B., Kühnle S., Nicotera P., Inhibition of mitochondrial ATP generation by nitric oxide switches apoptosis to necrosis. Experimental Cell Research 1999 249 2 396 403 2-s2.0-0033563776 10.1006/excr.1999.4514 (Pubitemid 29397947)
129. Mukherjee S. K., Klaidman L. K., Yasharel R., Adams J. D. Jr., Increased brain NAD prevents neuronal apoptosis in vivo. European Journal of Pharmacology 1997 330 1 27 34 2-s2.0-0030741051 10.1016/S0014-2999(97)00171-4 (Pubitemid 27304031)
130. Lelli J. L. Jr., Becks L. L., Dabrowska M. I., Hinshaw D. B., ATP converts necrosis to apoptosis in oxidant-injured endothelial cells. Free Radical Biology and Medicine 1998 25 6 694 702 2-s2.0-0032190514 10.1016/S0891-5849(98)00107-5 (Pubitemid 28464936)
131. Lieberthal W., Menza S. A., Levine J. S., Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. American Journal of Physiology 1998 274 2 F315 F327 2-s2.0-0031989121
132. Ran Z.-H., Rayet B., Rommelaere J., Faisst S., Parvovirus H-1-induced cell death: influence of intracellular NAD consumption on the regulation of necrosis and apoptosis. Virus Research 1999 65 2 161 174 2-s2.0-0032743996 10.1016/S0168-1702(99)00115-X
133. Crowley C. L., Payne C. M., Bernstein H., Bernstein C., Roe D., The NAD+ precursors, nicotinic acid and nicotinamide protect cells against apoptosis induced by a multiple stress inducer, deoxycholate. Cell Death and Differentiation 2000 7 3 314 326 2-s2.0-0034108869 (Pubitemid 30192980)
134. De Murcia G., Huletsky A., Lamarres D., Modulation of chromatin superstructure induced by poly(ADP-ribose) synthesis and degradation. Journal of Biological Chemistry 1986 261 15 7011 7017 2-s2.0-0022834642 (Pubitemid 17219474)
135. Lindahl T., Satoh M. S., Poirier G. G., Klungland A., Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks. Trends in Biochemical Sciences 1995 20 10 405 411 2-s2.0-0028865245 10.1016/S0968-0004(00)89089-1
136. Martín-Oliva D., O'Valle F., Muoz-Gámez J. A., Valenzuela M. T., Nuez M. I., Aguilar M., Ruiz De Almodóvar J. M., Garcia Del Moral R., Oliver F. J., Crosstalk between PARP-1 and NF- κ B modulates the promotion of skin neoplasia. Oncogene 2004 23 31 5275 5283 2-s2.0-3442890964 10.1038/sj.onc.1207696 (Pubitemid 39005803)
137. Baldwin A. S., The transcription factor NF- κ B and human disease. Journal of Clinical Investigation 2001 107 1 3 6 2-s2.0-0035174615
138. Brand K., Bauerle P. A., Walli A. K., Neumeier D., The role of NF-kappa B in the pathogenesis of atherosclerosis. Journal of Physiology 1996 491P S2 S2
139. Budunova I. V., Perez P., Vaden V. R., Spiegelman V. S., Slaga T. J., Jorcano J. L., Increased expression of p50-NF- κ B and constitutive activation of NF- κ B transcription factors during mouse skin carcinogenesis. Oncogene 1999 18 52 7423 7431 2-s2.0-0033539885 (Pubitemid 30035043)
140. Hassa P. O., Hottiger M. O., A role of poly (ADP-Ribose) polymerase in NF- κ B transcriptional activation. Biological Chemistry 1999 380 7-8 953 959 2-s2.0-0032863224 10.1515/BC.1999.118 (Pubitemid 29412755)
141. Oliver F. J., Menissier-de Murcia J., Nacci C., Decker P., Andriantsitohaina R., Muller S., De La Rubia G., Stoclet J. C., De Murcia G., Resistance to endotoxic shock as a consequence of defective NF- κ B activation in poly (ADP-ribose) polymerase-1 deficient mice. EMBO Journal 1999 18 16 4446 4454 2-s2.0-0344721492 10.1093/emboj/18.16.4446 (Pubitemid 29391254)
142. Martin-Oliva D., Aguilar-Quesada R., O'Valle F., Muoz-Gámez J. A., Martínez-Romero R., García Del Moral R., Ruiz De Almodóvar J. M., Villuendas R., Piris M. A., Oliver F. J., Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis. Cancer Research 2006 66 11 5744 5756 2-s2.0-33745288540 10.1158/0008-5472.CAN-05-3050 (Pubitemid 43927128)
143. Pero R. W., Axelsson B., Siemann D., Chaplin D., Dougherty G., Newly discovered anti-inflammatory properties of the benzamides and nicotinamides. Molecular and Cellular Biochemistry 1999 193 1-2 119 125 2-s2.0-0032917035 (Pubitemid 29176591)
144. Nozaki T., Fujihara H., Watanabe M., Tsutsumi M., Nakamoto K., Kusuoka O., Kamada N., Suzuki H., Nakagama H., Sugimura T., Masutani M., Parp-1 deficiency implicated in colon and liver tumorigenesis induced by azoxymethane. Cancer Science 2003 94 6 497 500 2-s2.0-0038640934 (Pubitemid 36849712)
145. Yeo E.-J., Chun Y.-S., Park J.-W., New anticancer strategies targeting HIF-1. Biochemical Pharmacology 2004 68 6 1061 1069 2-s2.0-4143050461 10.1016/j.bcp.2004.02.040 (Pubitemid 39094271)
146. Ueda M., Telomerase in cutaneous carcinogenesis. Journal of Dermatological Science 2000 23 1 S37 S40 2-s2.0-0034162139 10.1016/S0923- 1811(99)00075-4 (Pubitemid 30182549)
147. Oren M., Decision making by p53: life, death and cancer. Cell Death and Differentiation 2003 10 4 431 442 2-s2.0-0038075338 10.1038/sj.cdd.4401183 (Pubitemid 36626355)
148. Brooks C. L., Gu W., Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Current Opinion in Cell Biology 2003 15 2 164 171 2-s2.0-0037377060 10.1016/S0955-0674(03)00003-6 (Pubitemid 36332191)
149. Simbulan-Rosenthal C. M., Rosenthal D. S., Luo R., Smulson M. E., Poly(ADP-ribosyl)ation of p53 during apoptosis in human osteosarcoma cells. Cancer Research 1999 59 9 2190 2194 2-s2.0-0033135756 (Pubitemid 29217684)
150. Whitacre C. M., Hashimoto H., Tsai M.-L., Chatterjee S., Berger S. J., Berger N. A., Involvement of NAD-polyADP-Ribose) metabolism in p53 regulation and its consequences. Cancer Research 1995 55 17 3697 3701 2-s2.0-0029099358
151. Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A. Jr., Butel J. S., Bradley A., Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992 356 6366 215 221 2-s2.0-0026561121 10.1038/356215a0
152. + modulates p53 DNA binding specificity and function. Molecular and Cellular Biology 2004 24 22 9958 9967 2-s2.0-7644226719 10.1128/MCB.24.22.9958-9967.2004 (Pubitemid 39458821)